bioresearch-filters-purificationFeaturedArticles

  1. Cell 2025, Advanced Therapies USA Taught Me Why Platformization Is No Longer Optional 12/10/2025

    True scalability and global-ready CGT manufacturing depends on platformization that tightly integrates MES, ERP, LIMS, and related systems into a harmonized, leadership-driven digital backbone that treats data as a strategic asset.

  2. Tech Transfer 2025 – A High-Stakes Game Of Trust 8/4/2025

    Trust us. You'll want to read this editorial from Chief Editor Louis Garguilo, who was (gently) reminded he hadn't visited the subject of tech transfer in a while. He answers the questions both sponsors and CDMOs ask to gain the trust to make a tech transfer work for both sides.

  3. A Bioethicist Weighs In On Obesity Drugs 10/31/2024

    Anne Zimmerman, editor-in-chief of the Columbia University online journal, Voices in Bioethics discusses her concerns over the use of GLP-1 weight loss drugs in the U.S.

  4. Wi-Fi 7: Start Me Up 1/3/2024

    Soon to be all the rage, Wi-Fi 7 is coming and I ain’t too proud to beg that it happens soon. I won’t get angry or full of doom and gloom waiting for that day because time is on my side. But until certification day comes, I’ll shine a light on this new Wi-Fi standard and come to your emotional rescue.

  5. Bioprocess Online's 2025 Editorial Reflections 12/23/2025

    Bioprocess Online's chief editor, Tyler Menichiello, reflects on the year and provides a preview of what to expect in 2026.

  6. Lilly's CEO Building On The Trump Agenda 5/12/2025

    “We hadn’t built a new site in the U.S. in more than 40 years until the first set of Trump tax cuts, so we need to see those either extended or improved to support this,” Eli Lilly CEO David Ricks recently said, announcing — in Washington, DC — plans to invest $27 billion to build four new manufacturing plants in the U.S.

  7. Plodding Toward Better Data Integration & SSO 10/23/2024

    Laura Hilty, a principal at HealthX Ventures, talks about the need to better integrate data platforms and improve/enable single sign-on (SSO) solutions so sites can lessen their administrative burden.

  8. Inside Cell & Gene Live "How To Reduce Batch-To-Batch Variation In Cell Therapy Manufacturing" 2/26/2024

    Here's a recap of our recent Cell & Gene Live, How to Reduce Batch-to-Batch Variation in Cell Therapy Manufacturing, featuring expert panelists, Omkar Kawalekar, Ph.D., Head of Manufacturing and Supply Chain at NextGen Therapies Consulting at Deloitte and Donna Rill, Chief Technology Officer at Triumvira Immunologics.

  9. Is A One-Time Cure for HIV on the Horizon? 5/14/2024

    Addimmune's CMO, Dr. Marcus Conant, shares information about the company's lead asset, AGT103-T, which has been designed to provide a functional cure for HIV.

  10. A Day In The Life Of A CMC Professional 8/1/2024

    This CMC (chemistry, manufacturing and control) professional spends a good deal of time thinking about and interacting with his CDMOs. Through his experience, he knows that ineluctably some form of challenge will arise. Just another day at the office?